Acura Pharmaceuticals Probability of Future OTC Stock Price Finishing Over 20.44

ACURDelisted Stock  USD 0.05  0.00  0.00%   
Acura Pharmaceuticals' future price is the expected price of Acura Pharmaceuticals instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Acura Pharmaceuticals performance during a given time horizon utilizing its historical volatility. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in employment.
  
Please specify Acura Pharmaceuticals' target price for which you would like Acura Pharmaceuticals odds to be computed.

Acura Pharmaceuticals Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Acura Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Acura Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Acura Pharmaceuticals is not yet fully synchronised with the market data
Acura Pharmaceuticals has some characteristics of a very speculative penny stock
Acura Pharmaceuticals has a very high chance of going through financial distress in the upcoming years
The company currently holds 105 K in liabilities with Debt to Equity (D/E) ratio of 2.4, implying the company greatly relies on financing operations through barrowing. Acura Pharmaceuticals has a current ratio of 0.84, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Acura Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, Acura Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Acura Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Acura to invest in growth at high rates of return. When we think about Acura Pharmaceuticals' use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 3.57 M. Net Loss for the year was (1.21 M) with profit before overhead, payroll, taxes, and interest of 1.79 M.
Acura Pharmaceuticals currently holds about 89 K in cash with (719 K) of positive cash flow from operations.
Roughly 19.0% of Acura Pharmaceuticals shares are held by company insiders

Acura Pharmaceuticals Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Acura OTC Stock often depends not only on the future outlook of the current and potential Acura Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Acura Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding21.6 M

Acura Pharmaceuticals Technical Analysis

Acura Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Acura OTC Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Acura Pharmaceuticals. In general, you should focus on analyzing Acura OTC Stock price patterns and their correlations with different microeconomic environments and drivers.

Acura Pharmaceuticals Predictive Forecast Models

Acura Pharmaceuticals' time-series forecasting models is one of many Acura Pharmaceuticals' otc stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Acura Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the otc stock market movement and maximize returns from investment trading.

Things to note about Acura Pharmaceuticals

Checking the ongoing alerts about Acura Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Acura Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Acura Pharmaceuticals is not yet fully synchronised with the market data
Acura Pharmaceuticals has some characteristics of a very speculative penny stock
Acura Pharmaceuticals has a very high chance of going through financial distress in the upcoming years
The company currently holds 105 K in liabilities with Debt to Equity (D/E) ratio of 2.4, implying the company greatly relies on financing operations through barrowing. Acura Pharmaceuticals has a current ratio of 0.84, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Acura Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, Acura Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Acura Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Acura to invest in growth at high rates of return. When we think about Acura Pharmaceuticals' use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 3.57 M. Net Loss for the year was (1.21 M) with profit before overhead, payroll, taxes, and interest of 1.79 M.
Acura Pharmaceuticals currently holds about 89 K in cash with (719 K) of positive cash flow from operations.
Roughly 19.0% of Acura Pharmaceuticals shares are held by company insiders
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in employment.
You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Consideration for investing in Acura OTC Stock

If you are still planning to invest in Acura Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Acura Pharmaceuticals' history and understand the potential risks before investing.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Commodity Directory
Find actively traded commodities issued by global exchanges
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency